Get started
Author

David Seiden

Observed names: D J Seiden, D SEIDEN, D Seiden, DAVID SEIDEN, David J Seiden, David J. Seiden, David Joshua Seiden
Observed institutions: University of California San Diego, Mount Sinai Medical Center, Takeda (United States), Fort Leavenworth Unified School District 207, Broward Health, Centre de Recherche sur la Conservation, Harmony Biosciences (United States), Northeast Ohio Medical University
ORCID: 0000-0002-6548-2042
Observed ORCID: 0000-0002-6548-2042
OpenAlex ID: A5027123033
An efficacy, safety, and dose–response study of Ramelteon in patients with chronic primary insomnia
2005 · M ERMAN, D SEIDEN, et al. · Sleep Medicine · 434
Efficacy and Safety of Doxepin 1 mg, 3 mg, and 6 mg in Adults with Primary Insomnia
2007 · Thomas Roth, Roberta Rogowski, et al. · SLEEP · 338
PDF
Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia
2006 · Thomas Roth, David Seiden, et al. · Sleep Medicine · 265
Gender Discrimination and Sexual Harassment in Medical Education
2002 · Lois Margaret Nora, Margaret A. McLaughlin, et al. · Academic Medicine · 157
A 2-Week Efficacy and Safety Study of Eszopiclone in Elderly Patients with Primary Insomnia
2005 · Martin Scharf, Milton Erman, et al. · SLEEP · 143
Nightly Variability in the Indices of Sleep-Disordered Breathing in Men Being Evaluated for Impotence With Consecutive Night Polysomnograms
1996 · Alejandro D. Chediak, Juan C. Acevedo-Crespo, et al. · SLEEP · 140
A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia
2007 · Thomas Roth, David Seiden, et al. · Current Medical Research and Opinion · 126
SA4Ag, a 4-antigen Staphylococcus aureus vaccine, rapidly induces high levels of bacteria-killing antibodies
2017 · Elizabeth Begier, David Joshua Seiden, et al. · Vaccine · 90
Solriamfetol for the Treatment of Excessive Sleepiness in OSA
2018 · Patrick J. Strollo, Jan Hedner, et al. · CHEST Journal · 82
PDF
Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study
2016 · Robert W. Frenck, C. Buddy Creech, et al. · Vaccine · 64
PDF
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial
2016 · C. Buddy Creech, Robert W. Frenck, et al. · Vaccine · 58
PDF
Once-nightly sodium oxybate (FT218) demonstrated improvement of symptoms in a phase 3 randomized clinical trial in patients with narcolepsy
2021 · Clete A Kushida, Colin M Shapiro, et al. · SLEEP · 57
PDF
A randomized Phase 2 study to evaluate the orexin-2 receptor antagonist seltorexant in individuals with insomnia without psychiatric comorbidity
2018 · Peter De Boer, Wayne C Drevets, et al. · Journal of Psychopharmacology · 53
APD125, a Selective Serotonin 5-HT2A Receptor Inverse Agonist, Significantly Improves Sleep Maintenance in Primary Insomnia
2008 · Russell Rosenberg, David J. Seiden, et al. · SLEEP · 44
A Randomized, Double-Blind, Single-Dose, Placebo-Controlled, Multicenter, Polysomnographic Study of Gabapentin in Transient Insomnia Induced by Sleep Phase Advance
2014 · Russell P. Rosenberg, Steven G. Hull, et al. · Journal of Clinical Sleep Medicine · 34
PDF
Effect of FT218, a Once-Nightly Sodium Oxybate Formulation, on Disrupted Nighttime Sleep in Patients with Narcolepsy: Results from the Randomized Phase III REST-ON Trial
2022 · Thomas Roth, Yves Dauvilliers, et al. · CNS Drugs · 31
PDF
Efficacy and Tolerability of Armodafinil
2011 · Milton K. Erman, David J. Seiden, et al. · Journal of Occupational and Environmental Medicine · 25
Efficacy and Tolerability of Modified-Release Indiplon in Elderly Patients With Chronic Insomnia: Results of a 2-Week Double-Blind, Placebo-Controlled Trial
2006 · R. Bruce Lydiard, D. Alan Lankford, et al. · Journal of Clinical Sleep Medicine · 23
PDF
Immunogenicity and safety of an AS03-adjuvanted H7N1 vaccine in adults 65 years of age and older: A phase II, observer-blind, randomized, controlled trial
2017 · Anuradha Madan, Murdo Ferguson, et al. · Vaccine · 14
PDF
The Effect of Armodafinil on Patient-Reported Functioning and Quality of Life in Patients With Excessive Sleepiness Associated With Shift Work Disorder
2012 · Milton K. Erman, Ronghua Yang, et al. · The Primary Care Companion For CNS Disorders · 13
Randomized, crossover, open-label study of the relative bioavailability and safety of FT218, a once-nightly sodium oxybate formulation: Phase 1 study in healthy volunteers
2022 · Richard Bogan, Michael J. Thorpy, et al. · Sleep Medicine · 12
PDF
Pharmacokinetics of FT218, a Once-Nightly Sodium Oxybate Formulation in Healthy Adults
2021 · David Seiden, Charles Tyler, et al. · Clinical Therapeutics · 12
A Randomized, Crossover, Pharmacokinetics Evaluation of a Novel Continuous Release and Absorption Melatonin Formulation
2019 · David J. Seiden, Syed M. Shah · The Primary Care Companion For CNS Disorders · 10
Preferences for Attributes of Sodium Oxybate Treatment: A Discrete Choice Experiment in Patients with Narcolepsy
2022 · Jordan Dubow, Alon Y Avidan, et al. · Patient Preference and Adherence · 8
PDF
A proof-of-concept study of pitolisant for excessive daytime sleepiness in patients with Prader-Willi syndrome
2025 · Amee Revana, Rakesh Bhattacharjee, et al. · Journal of Clinical Sleep Medicine · 3
PDF
Works count: 66
Citation count: 2,246
H-index: 18
I10-index: 23
Year
Topic
Type